← FDA DRUG APPROVALS

FDA NDA · NDA017046

KAON CL-10

Sponsor: SAVAGE LABS

APPLICATION
NDA017046
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

KAON CL-10Discontinued
POTASSIUM CHLORIDE 10MEQ · TABLET, EXTENDED RELEASE · ORAL
KAON CLDiscontinued
POTASSIUM CHLORIDE 6.7MEQ · TABLET, EXTENDED RELEASE · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →